[go: up one dir, main page]

NO178497C - Fremgangsmåte for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmåten - Google Patents

Fremgangsmåte for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmåten

Info

Publication number
NO178497C
NO178497C NO913686A NO913686A NO178497C NO 178497 C NO178497 C NO 178497C NO 913686 A NO913686 A NO 913686A NO 913686 A NO913686 A NO 913686A NO 178497 C NO178497 C NO 178497C
Authority
NO
Norway
Prior art keywords
intermediates
preparation
substituted guanine
guanine derivatives
derivatives
Prior art date
Application number
NO913686A
Other languages
English (en)
Norwegian (no)
Other versions
NO913686L (no
NO178497B (no
NO913686D0 (no
Inventor
Boerge Alhede
Finn Priess Clausen
Joergen Juhl-Christensen
Klaus K Mccluskey
Herbert Preikschat
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of NO913686L publication Critical patent/NO913686L/no
Publication of NO913686D0 publication Critical patent/NO913686D0/no
Publication of NO178497B publication Critical patent/NO178497B/no
Publication of NO178497C publication Critical patent/NO178497C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO913686A 1989-03-20 1991-09-19 Fremgangsmåte for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmåten NO178497C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK135489A DK135489D0 (da) 1989-03-20 1989-03-20 Fremgangsmaade til fremstilling af 9-substituerede guaninderivater og mellemprodukter til brug ved fremgangsmaaden
PCT/DK1990/000077 WO1990011283A1 (en) 1989-03-20 1990-03-19 A process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process

Publications (4)

Publication Number Publication Date
NO913686L NO913686L (no) 1991-09-19
NO913686D0 NO913686D0 (no) 1991-09-19
NO178497B NO178497B (no) 1996-01-02
NO178497C true NO178497C (no) 1996-04-10

Family

ID=8103930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913686A NO178497C (no) 1989-03-20 1991-09-19 Fremgangsmåte for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmåten

Country Status (28)

Country Link
US (1) US5223619A (el)
EP (1) EP0464112B1 (el)
KR (1) KR0142098B1 (el)
AR (1) AR245719A1 (el)
AT (1) ATE112568T1 (el)
BG (1) BG60590B1 (el)
BR (1) BR9007230A (el)
CA (1) CA2047217A1 (el)
CS (1) CS275359B2 (el)
DD (1) DD293116A5 (el)
DE (1) DE69013146T2 (el)
DK (2) DK135489D0 (el)
ES (1) ES2061023T3 (el)
FI (1) FI97387C (el)
GE (1) GEP19971014B (el)
GR (1) GR1001096B (el)
HR (1) HRP920907B1 (el)
HU (1) HU206715B (el)
IE (1) IE62042B1 (el)
LT (1) LT3183B (el)
LV (1) LV10455B (el)
NO (1) NO178497C (el)
PL (1) PL163313B1 (el)
RO (1) RO109737B1 (el)
RU (2) RU2090566C1 (el)
SI (1) SI9010545A (el)
WO (1) WO1990011283A1 (el)
YU (1) YU47343B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264599B1 (it) * 1993-06-14 1996-10-04 Solar Chem Sa Processo per la sintesi della 9-(2-idrossietossimetil)- guanina
GB9520364D0 (en) * 1995-10-05 1995-12-06 Chiroscience Ltd Compouundds
US6860928B2 (en) 2002-09-04 2005-03-01 Xerox Corporation Alkylated urea and triaminotriazine compounds and phase change inks containing same
US6811595B2 (en) 2002-09-04 2004-11-02 Xerox Corporation Guanidinopyrimidinone compounds and phase change inks containing same
US6872243B2 (en) 2002-09-04 2005-03-29 Xerox Corporation Phase change inks containing gelator additives
US6761758B2 (en) 2002-09-04 2004-07-13 Xerox Corporation Alkylated tetrakis(triaminotriazine) compounds and phase change inks containing same
US7144450B2 (en) 2004-12-04 2006-12-05 Xerox Corporation Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds
US7560587B2 (en) 2004-12-04 2009-07-14 Xerox Corporation Bis[urea-urethane] compounds
US7314949B2 (en) 2004-12-04 2008-01-01 Xerox Corporation Trans-1,2-cyclohexane bis(urea-urethane) compounds
US7317122B2 (en) 2004-12-04 2008-01-08 Xerox Corporation Curable trans-1,2-cyclohexane bis(urea-urethane) compounds
US7153349B2 (en) 2004-12-04 2006-12-26 Xerox Corporation Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds
US7220300B2 (en) 2004-12-04 2007-05-22 Xerox Corporation Phase change inks containing bis(urea-urethane) compounds
CN105705284B (zh) 2013-10-29 2019-05-31 舒瑞普国际股份公司 使用丝网印刷钎焊材料钎焊板式换热器的方法;利用该方法制造的板式换热器
CN115504977B (zh) * 2022-09-23 2024-02-09 海南锦瑞制药有限公司 更昔洛韦的制备方法及注射用更昔洛韦的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56152437U (el) * 1980-04-14 1981-11-14
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US4602089A (en) * 1982-03-12 1986-07-22 Newport Pharmaceuticals, Inc. Process for preparing purine compounds
JPS6055071B2 (ja) * 1982-04-16 1985-12-03 四国化成工業株式会社 イミダゾリル琥珀酸化合物および該化合物を用いるエポキシ樹脂硬化方法
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
EP0219838A3 (en) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Carbocyclic purine nucleosides, their production and use
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
DE69013146D1 (de) 1994-11-10
NO913686L (no) 1991-09-19
HU902874D0 (en) 1991-12-30
IE900994L (en) 1990-09-20
ATE112568T1 (de) 1994-10-15
SI9010545A (en) 1997-08-31
HUT59141A (en) 1992-04-28
US5223619A (en) 1993-06-29
RU2042668C1 (ru) 1995-08-27
NO178497B (no) 1996-01-02
ES2061023T3 (es) 1994-12-01
GEP19971014B (en) 1997-04-18
DD293116A5 (de) 1991-08-22
CS9001365A3 (en) 1992-02-19
PL163313B1 (pl) 1994-03-31
DK135489D0 (da) 1989-03-20
YU47343B (sh) 1995-01-31
DK0464112T3 (da) 1995-03-13
AR245719A1 (es) 1994-02-28
FI97387B (fi) 1996-08-30
LT3183B (en) 1995-03-27
FI914418A0 (fi) 1991-09-19
WO1990011283A1 (en) 1990-10-04
NO913686D0 (no) 1991-09-19
BG60590B1 (en) 1995-09-29
KR0142098B1 (ko) 1998-06-01
CA2047217A1 (en) 1990-09-21
GR1001096B (el) 1993-04-28
GR900100212A (en) 1990-07-31
LV10455B (en) 1995-08-20
EP0464112A1 (en) 1992-01-08
HU206715B (en) 1992-12-28
KR920701208A (ko) 1992-08-11
LTIP297A (en) 1994-08-25
RO109737B1 (ro) 1995-05-30
EP0464112B1 (en) 1994-10-05
HRP920907B1 (en) 1998-06-30
IE62042B1 (en) 1994-12-14
YU54590A (sh) 1992-12-21
DE69013146T2 (de) 1995-02-16
FI97387C (fi) 1996-12-10
RU2090566C1 (ru) 1997-09-20
BR9007230A (pt) 1992-02-25
CS275359B2 (en) 1992-02-19
BG95145A (bg) 1993-12-24
HRP920907A2 (hr) 1994-04-30
LV10455A (lv) 1995-02-20

Similar Documents

Publication Publication Date Title
FI900085L (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
FI905941A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
HUP9801836A2 (hu) Guaninszármazékok és eljárás ezek előállítására
KR960701058A (ko) 2-벤질-폴리사이클릭 구아닌 유도체 및 이의 제조방법(2-Benzyl-polycyslic guanine derivative and process for preparing them)
FI875660L (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi
FI90346C (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI913477L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten imidatsoli-fenyyli-imidatso/1,2-a/pyridiini- ja imidatsoli-fenyyli-imidatso/1,2-a/pyrimidiinijohdannaisten valmistamiseksi
FI885943L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten adenosiinijohdannaisten valmistamiseksi ja välituotteita
FR2637374B1 (fr) Procede d'inspection non-agressive d'articles creux
NO177057C (no) Fremgangsmåte for fremstilling av pyrrolopyrimidiner og mellomprodukter derav
EP0421946A3 (en) 3-indolepyruvic acid derivatives their method of production and therapeutic use
NO178497C (no) Fremgangsmåte for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmåten
IT8768027A0 (it) Derivati di 1 piperazinil pirimidina loro preparazione e impiego in terapia e cosmesi
FI923527L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi
FI895417A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-halometylideeninukleosidien valmistamiseksi
FI900813A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bentsatsepiini- ja bentsotiatsepiinijohdannaisten valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
EP0420194A3 (en) Uracil derivatives and their production and use
DK183488A (da) Furanderivater og anvendelse deraf
NO173823C (no) Fremgangsmaate for fremstilling av (s)- -ethyl-2-oxo-1-pyrrolidinacetamid og mellomprodukt for anvendelse ved fremgangsmaaten
YU236989A (en) Derivatives of 2-iminobenzothiazoline and process for obtaining thereof
FI894604L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridyyli- ja pyrimidyylipiperatsiinijohdannaisten valmistamiseksi
NO175490C (no) Fremgangsmåte for fremstilling og anvendelse av en aluminiumsilisiumlegeringsartikkel
DK480588A (da) Tricykliske sammensmeltede pyrimidinderivater samt fremstilling og anvendelse deraf
FI920566L (fi) Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi